Section 4.4 of the SPC for Nexium has been updated to include further information regarding potential interactions as a result of CYP2C19 inhibition.
Section 4.5 has also been updated to include trial data in relation to the interaction between omeprazole and clopidogrel.
See below for link to SPC and full prescribing information.